MAPT and Alzheimer disease: Protein kinase CK2 (formerly known as Casein Kinase II), is a serine/threonine kinase that has emerged as an important regulator of neuroinflammation and protein homeostasis in several neurodegenerative diseases [16-18], and it has previously been connected to tau pathology in AD[19-22].